Maintenance strategy: Microdosing can serve as a maintenance dose after achieving goal weight
GLP-1 medications carry potential risks and side effects that should be discussed with your provider
Heesakker, G
Mounjaro, Zepbound, and Trulicitys labels include robust, FDA-approved warnings, and have always warned of potential gastrointestinal adverse reactions, sometimes severe. He added, As part of our routine safety review process for Mounjaro, Zepbound and Trulicity, we work closely with regulators regarding potential safety topics, and we will continue to review data to ensure that appropriate safety information is available to prescribers. Ana Santos Rutschman, a health law professor at Villanova University, said proving the drugs caused certain outcomes will be an issue as the legal battle unfolds, along with the extent and timing of warnings
As a result, GLP-1 agonists help you to feel full lowering your appetite and causing you to lose weight with much higher success rate than dieting alone
In early clinical trials, patients on GLP-1 agonists have achieved weight loss of 1520%, compared to the 510% typically seen with previous medications. Holistic approach to GLP-1 drugs Beyond weight loss, GLP-1 agonists have demonstrated the ability to reduce major cardiovascular events, combat fatty liver disease and alleviate obesity-related complications such as knee pain, sleep apnea, and acid reflux
